StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Medpace's market cap was $18.55B on Nov 11, 2026, against $16.69B a year earlier. Over the last 5 years it ranged from $4.57B to $18.55B, with a median of $9.74B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$18.55B+17.3%
2025Dec 31, 2025$15.82B+53.2%
2024Dec 31, 2024$10.33B+9.8%
2023Dec 29, 2023$9.41B+42.4%
2022Dec 30, 2022$6.61B-15.5%
2021Dec 31, 2021$7.82B+57.1%
2020Dec 31, 2020$4.98B+64.4%
2019Dec 31, 2019$3.03B+60.7%
2018Dec 31, 2018$1.88B+38.9%
2017Dec 29, 2017$1.36B-7.7%
2016Dec 30, 2016$1.47B–

More Medpace figures

See a number that looks wrong?